Immunotherapy

Transplant drug could boost the power of brain tumor treatments

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   Investigators at the University of Michigan have made headway in one of the most difficult areas of immunotherapy for malignant glioma. http://www.uofmhealth.org/news/archive/201409/transplant-drug-could-boost-power-brain-tumor-treatments-u-m Immunotherapy is the use of a natural immune response […]

Guiding Brain Tumor Resection Using Surface-Enhanced Raman Scattering Nanoparticles and a Hand-Held Raman Scanner

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   Investigators from Sloan-Kettering and the Fred Hutchinson Cancer Institute have published recently a technology that may increase our ability to perform a more complete and accurate resections of malignant brain tumors. […]

Gene Therapy Enhances Chemotherapy Tolerance and Efficacy in Glioblastoma Patients

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   Recently, investigators at the Fred Hutchinson Cancer Institute in Seattle published interesting findings in the Journal of Clinical Investigation, a highly regarded translational research journal. The title of their article was […]

Dr. Charles Cobbs
Neurosurgeon and The Gregory Foltz Endowed Director of the Ben and Catherine Ivy Center for Advanced Brain Tumor Treatment at Swedish Neuroscience Institute

Genetic Markers in the Treatment of Brain Cancer

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   An article recently published in the journal Oncotarget has received quite a bit of publicity recently.   http://m.medicalxpress.com/news/2014-08-genetic-brain-cancer.html   The press release indicates that a new genetic test may change how brain cancers are treated. […]

Progesterone and Treating Glioblastoma Multiforme

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   Recently a paper was published in the Journal of Steroid Biochemistry and Molecular Biology entitled “Anti-tumor effects of progesterone in human glioblastoma multiforme: Role of PI3K/Akt/mTOR signaling”.  http://news.emory.edu/stories/2014/06/labland_progesterone_for_brain_cancer/campus.html  This paper has received some attention amongst the […]

Newly Identified Brain Cancer Mutation Hopes To Aid Drug Development

Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists     Duke University investigators have recently published and esoteric molecular genetics research finding that may increase our ability to understand the biology of pediatric intrinsic brainstem gliomas.  http://corporate.dukemedicine.org/news_and_publications/news_office/news/newly-identified-brain-cancer-mutation-will-aid-drug-development?utm_source=corporate.dukemedicine.org&utm_medium=rss&utm_campaign=RSS_news These are devastating […]

Dr. Charles Cobbs, The Gregory Foltz Endowed Director of the Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment at Swedish Neuroscience Institute Awarded $50,000 grant by The Musella Foundation

  Charles S. Cobbs, MD The Gregory Foltz, MD Endowed Director Ben & Catherine Ivy Center for Advanced Brain Tumor Treatment Swedish Neuroscience Specialists   I am very excited to announce that my research group has been awarded a research grant from The Musella Foundation for Brain Tumor Research and Information, Inc., which will allow […]